Laketa Shavonne Woods, LVN | |
1109 Fairview St, Texarkana, AR 71854-7515 | |
(903) 651-1479 | |
Not Available |
Full Name | Laketa Shavonne Woods |
---|---|
Gender | Female |
Speciality | Licensed Vocational Nurse |
Location | 1109 Fairview St, Texarkana, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1730680299 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164X00000X | Licensed Vocational Nurse | 300587 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Laketa Shavonne Woods, LVN 1109 Fairview St, Texarkana, AR 71854-7515 Ph: (903) 651-1479 | Laketa Shavonne Woods, LVN 1109 Fairview St, Texarkana, AR 71854-7515 Ph: (903) 651-1479 |
News Archive
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease. A team of Purdue University researchers has synthesized a molecule that finds and penetrates prostate cancer cells and has created imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo.
International Stem Cell Corporation , and a new firm to be formed by John Mauldin announced today the formation of a new joint marketing venture to launch a line of skin care products developed by ISCO's wholly owned subsidiary, Lifeline Skin Care, Inc. Mauldin, a significant marketing talent, is president of Millennium Wave Investments and author of an economic letter that goes to over 1.5 million readers.
People with Alzheimer's disease are less likely to have cataract surgery than people without Alzheimer's disease. The procedure rate starts to decrease already one year after the diagnosis, according to a new study from the University of Eastern Finland.
Giving mothers and children in developing countries twice the WHO recommended doses of vitamin A, as suggested by an international vitamin group, does not have a beneficial effect.
A new family of genes called Novel Structure Proteins (NSP) discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology could have the potential for predicting the possibility of tumor growth in a patient.
› Verified 4 days ago